Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAD-PD: Antidepressants in Parkinson's Disease
NCT00086190Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Jun 2005
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of paroxetine, venlafaxine in major depressive disorder (MDD), sponsored by University of Rochester. Started Jun 2005; status: completed.
02
Drugs
paroxetinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00086190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086190.